{"status": "Succeeded", "recognitionResults": [{"page": 1, "clockwiseOrientation": 0.29, "width": 1700, "height": 2236, "unit": "pixel", "lines": [{"boundingBox": [268, 185, 602, 187, 602, 231, 267, 229], "text": "Specific Findings", "words": [{"boundingBox": [273, 187, 427, 188, 426, 229, 273, 228], "text": "Specific"}, {"boundingBox": [435, 188, 602, 187, 602, 231, 435, 229], "text": "Findings"}]}, {"boundingBox": [189, 263, 229, 262, 228, 301, 188, 302], "text": "A.", "words": [{"boundingBox": [192, 262, 227, 262, 228, 299, 193, 300], "text": "A."}]}, {"boundingBox": [270, 263, 720, 266, 720, 307, 269, 303], "text": "Reaction to IR Information", "words": [{"boundingBox": [281, 264, 429, 265, 430, 304, 281, 303], "text": "Reaction"}, {"boundingBox": [437, 265, 470, 265, 471, 304, 437, 304], "text": "to"}, {"boundingBox": [478, 265, 514, 266, 514, 304, 478, 304], "text": "IR"}, {"boundingBox": [521, 266, 719, 267, 719, 307, 522, 304], "text": "Information"}]}, {"boundingBox": [269, 348, 1275, 350, 1274, 384, 268, 383], "text": "Participants accept ACTOS as an effective glucose control agent, and", "words": [{"boundingBox": [278, 349, 450, 350, 451, 383, 279, 383], "text": "Participants"}, {"boundingBox": [457, 350, 553, 351, 554, 384, 458, 383], "text": "accept"}, {"boundingBox": [560, 351, 664, 351, 666, 384, 561, 384], "text": "ACTOS"}, {"boundingBox": [671, 351, 707, 351, 708, 384, 672, 384], "text": "as"}, {"boundingBox": [714, 351, 749, 351, 751, 384, 715, 384], "text": "an"}, {"boundingBox": [756, 351, 881, 352, 882, 384, 757, 384], "text": "effective"}, {"boundingBox": [888, 352, 1004, 351, 1005, 384, 889, 384], "text": "glucose"}, {"boundingBox": [1010, 351, 1113, 351, 1115, 384, 1012, 384], "text": "control"}, {"boundingBox": [1120, 351, 1211, 350, 1213, 384, 1121, 384], "text": "agent,"}, {"boundingBox": [1218, 350, 1272, 350, 1273, 384, 1220, 384], "text": "and"}]}, {"boundingBox": [277, 389, 703, 390, 702, 428, 276, 427], "text": "as a drug free of liver toxicity.", "words": [{"boundingBox": [279, 392, 313, 392, 314, 426, 280, 427], "text": "as"}, {"boundingBox": [320, 391, 340, 391, 341, 426, 320, 426], "text": "a"}, {"boundingBox": [347, 391, 411, 390, 411, 425, 348, 426], "text": "drug"}, {"boundingBox": [418, 390, 477, 390, 477, 425, 418, 425], "text": "free"}, {"boundingBox": [484, 390, 511, 390, 511, 425, 484, 425], "text": "of"}, {"boundingBox": [518, 390, 582, 391, 581, 426, 518, 425], "text": "liver"}, {"boundingBox": [588, 391, 702, 392, 701, 429, 588, 426], "text": "toxicity."}]}, {"boundingBox": [277, 456, 1253, 457, 1252, 491, 276, 490], "text": "If convinced by compelling clinical data that TZDs preserve beta cell", "words": [{"boundingBox": [278, 457, 299, 457, 299, 489, 277, 489], "text": "If"}, {"boundingBox": [305, 457, 452, 457, 452, 491, 305, 489], "text": "convinced"}, {"boundingBox": [458, 457, 497, 458, 496, 491, 458, 491], "text": "by"}, {"boundingBox": [503, 458, 664, 458, 665, 491, 503, 491], "text": "compelling"}, {"boundingBox": [671, 458, 781, 458, 782, 491, 671, 491], "text": "clinical"}, {"boundingBox": [787, 458, 845, 458, 846, 491, 788, 491], "text": "data"}, {"boundingBox": [851, 458, 911, 459, 912, 491, 852, 491], "text": "that"}, {"boundingBox": [917, 459, 991, 459, 992, 491, 918, 491], "text": "TZDs"}, {"boundingBox": [998, 459, 1125, 459, 1127, 490, 999, 491], "text": "preserve"}, {"boundingBox": [1131, 459, 1195, 459, 1197, 489, 1133, 490], "text": "beta"}, {"boundingBox": [1202, 459, 1250, 459, 1252, 488, 1203, 489], "text": "cell"}]}, {"boundingBox": [278, 497, 1280, 496, 1281, 531, 279, 532], "text": "function, many participants would feel compelled to use TZDs as first", "words": [{"boundingBox": [279, 497, 403, 497, 402, 532, 279, 532], "text": "function,"}, {"boundingBox": [410, 497, 490, 498, 489, 533, 409, 532], "text": "many"}, {"boundingBox": [497, 498, 671, 498, 670, 533, 496, 533], "text": "participants"}, {"boundingBox": [677, 498, 767, 498, 766, 533, 677, 533], "text": "would"}, {"boundingBox": [773, 498, 826, 498, 825, 533, 773, 533], "text": "feel"}, {"boundingBox": [833, 498, 986, 498, 986, 532, 832, 533], "text": "compelled"}, {"boundingBox": [993, 498, 1023, 498, 1022, 532, 992, 532], "text": "to"}, {"boundingBox": [1030, 498, 1087, 498, 1086, 532, 1029, 532], "text": "use"}, {"boundingBox": [1094, 498, 1167, 497, 1166, 531, 1093, 532], "text": "TZDs"}, {"boundingBox": [1174, 497, 1208, 497, 1207, 531, 1173, 531], "text": "as"}, {"boundingBox": [1215, 497, 1281, 497, 1281, 531, 1214, 531], "text": "first"}]}, {"boundingBox": [277, 537, 454, 542, 453, 574, 277, 570], "text": "line therapy.", "words": [{"boundingBox": [278, 538, 330, 539, 330, 571, 277, 571], "text": "line"}, {"boundingBox": [337, 540, 452, 543, 453, 574, 336, 571], "text": "therapy."}]}, {"boundingBox": [281, 602, 1227, 604, 1226, 638, 280, 637], "text": "Across all groups, the most commonly mentioned reasons NOT to", "words": [{"boundingBox": [281, 604, 378, 605, 379, 636, 282, 636], "text": "Across"}, {"boundingBox": [384, 605, 420, 605, 422, 637, 386, 636], "text": "all"}, {"boundingBox": [426, 605, 538, 605, 540, 637, 428, 637], "text": "groups,"}, {"boundingBox": [545, 605, 591, 605, 592, 637, 546, 637], "text": "the"}, {"boundingBox": [597, 605, 673, 605, 674, 637, 599, 637], "text": "most"}, {"boundingBox": [680, 605, 832, 605, 833, 638, 681, 637], "text": "commonly"}, {"boundingBox": [838, 605, 994, 605, 995, 638, 839, 638], "text": "mentioned"}, {"boundingBox": [1001, 605, 1117, 605, 1117, 638, 1001, 638], "text": "reasons"}, {"boundingBox": [1123, 604, 1189, 604, 1189, 639, 1123, 638], "text": "NOT"}, {"boundingBox": [1195, 604, 1227, 604, 1227, 639, 1195, 639], "text": "to"}]}, {"boundingBox": [280, 642, 1087, 644, 1086, 680, 279, 679], "text": "prescribe TZDs are 1) Cost, 2) Edema/weight gain, and 3)", "words": [{"boundingBox": [280, 644, 415, 644, 415, 678, 280, 677], "text": "prescribe"}, {"boundingBox": [421, 644, 497, 644, 497, 679, 421, 679], "text": "TZDs"}, {"boundingBox": [504, 644, 552, 644, 551, 679, 504, 679], "text": "are"}, {"boundingBox": [558, 644, 586, 644, 586, 680, 558, 679], "text": "1)"}, {"boundingBox": [593, 644, 669, 644, 669, 680, 593, 680], "text": "Cost,"}, {"boundingBox": [675, 644, 704, 644, 703, 680, 675, 680], "text": "2)"}, {"boundingBox": [710, 644, 916, 644, 916, 681, 710, 680], "text": "Edema/weight"}, {"boundingBox": [923, 644, 997, 645, 997, 681, 923, 681], "text": "gain,"}, {"boundingBox": [1003, 645, 1060, 645, 1059, 681, 1003, 681], "text": "and"}, {"boundingBox": [1066, 645, 1086, 645, 1086, 681, 1066, 681], "text": "3)"}]}, {"boundingBox": [276, 682, 516, 686, 515, 718, 275, 714], "text": "Reimbursement.", "words": [{"boundingBox": [278, 682, 515, 687, 515, 717, 278, 715], "text": "Reimbursement."}]}, {"boundingBox": [317, 767, 1331, 771, 1330, 807, 316, 804], "text": ". Participants overwhelmingly accept ACTOS as an effective glucose", "words": [{"boundingBox": [322, 768, 345, 769, 343, 803, 321, 802], "text": "."}, {"boundingBox": [367, 769, 540, 769, 539, 805, 366, 803], "text": "Participants"}, {"boundingBox": [547, 769, 776, 770, 775, 806, 546, 805], "text": "overwhelmingly"}, {"boundingBox": [783, 770, 881, 770, 879, 806, 782, 806], "text": "accept"}, {"boundingBox": [887, 770, 992, 770, 991, 806, 886, 806], "text": "ACTOS"}, {"boundingBox": [999, 770, 1034, 771, 1033, 807, 997, 807], "text": "as"}, {"boundingBox": [1041, 771, 1076, 771, 1075, 806, 1040, 807], "text": "an"}, {"boundingBox": [1083, 771, 1208, 771, 1207, 806, 1082, 806], "text": "effective"}, {"boundingBox": [1214, 771, 1330, 771, 1329, 806, 1213, 806], "text": "glucose", "confidence": "Low"}]}, {"boundingBox": [367, 804, 567, 807, 566, 840, 366, 837], "text": "control agent.", "words": [{"boundingBox": [368, 806, 471, 806, 470, 840, 367, 838], "text": "control"}, {"boundingBox": [477, 806, 567, 809, 567, 841, 476, 840], "text": "agent."}]}, {"boundingBox": [363, 853, 1309, 858, 1308, 896, 362, 892], "text": "Participants overwhelmingly accept ACTOS as a drug free of liver", "words": [{"boundingBox": [367, 856, 541, 857, 542, 892, 368, 890], "text": "Participants"}, {"boundingBox": [548, 857, 775, 858, 775, 894, 549, 892], "text": "overwhelmingly"}, {"boundingBox": [781, 858, 880, 859, 881, 895, 782, 894], "text": "accept"}, {"boundingBox": [887, 859, 993, 859, 993, 895, 887, 895], "text": "ACTOS"}, {"boundingBox": [999, 859, 1034, 859, 1034, 895, 999, 895], "text": "as"}, {"boundingBox": [1041, 859, 1063, 859, 1063, 895, 1041, 895], "text": "a"}, {"boundingBox": [1070, 858, 1136, 858, 1136, 895, 1070, 895], "text": "drug"}, {"boundingBox": [1142, 858, 1199, 858, 1199, 895, 1142, 895], "text": "free"}, {"boundingBox": [1206, 858, 1235, 858, 1235, 895, 1206, 895], "text": "of"}, {"boundingBox": [1241, 858, 1310, 858, 1309, 895, 1241, 895], "text": "liver"}]}, {"boundingBox": [368, 894, 480, 895, 480, 929, 367, 927], "text": "toxicity.", "words": [{"boundingBox": [368, 896, 480, 896, 480, 929, 368, 927], "text": "toxicity."}]}, {"boundingBox": [363, 945, 1350, 950, 1349, 986, 362, 981], "text": "Participants in all groups agree that insulin resistance is the primary", "words": [{"boundingBox": [367, 947, 539, 948, 539, 980, 368, 981], "text": "Participants"}, {"boundingBox": [545, 948, 576, 948, 576, 980, 545, 980], "text": "in"}, {"boundingBox": [582, 948, 619, 948, 619, 980, 582, 980], "text": "all"}, {"boundingBox": [626, 948, 728, 949, 727, 980, 626, 980], "text": "groups"}, {"boundingBox": [734, 949, 817, 949, 816, 980, 734, 980], "text": "agree"}, {"boundingBox": [823, 949, 880, 949, 879, 981, 823, 980], "text": "that"}, {"boundingBox": [886, 949, 986, 949, 985, 981, 885, 981], "text": "insulin"}, {"boundingBox": [992, 949, 1142, 950, 1141, 983, 991, 981], "text": "resistance"}, {"boundingBox": [1149, 950, 1177, 950, 1176, 983, 1147, 983], "text": "is"}, {"boundingBox": [1183, 950, 1231, 950, 1230, 984, 1182, 984], "text": "the"}, {"boundingBox": [1238, 950, 1348, 950, 1347, 986, 1236, 984], "text": "primary"}]}, {"boundingBox": [368, 981, 968, 985, 967, 1020, 367, 1016], "text": "or foundational defect in Type 2 diabetes.", "words": [{"boundingBox": [368, 985, 399, 985, 398, 1014, 368, 1014], "text": "or"}, {"boundingBox": [404, 984, 593, 983, 593, 1017, 404, 1015], "text": "foundational"}, {"boundingBox": [599, 983, 685, 984, 684, 1018, 598, 1017], "text": "defect"}, {"boundingBox": [690, 984, 717, 984, 716, 1018, 690, 1018], "text": "in"}, {"boundingBox": [729, 984, 797, 984, 796, 1019, 728, 1018], "text": "Type"}, {"boundingBox": [803, 985, 822, 985, 821, 1019, 802, 1019], "text": "2"}, {"boundingBox": [833, 985, 967, 987, 966, 1021, 832, 1019], "text": "diabetes."}]}, {"boundingBox": [361, 1036, 1357, 1037, 1356, 1073, 360, 1072], "text": "They are learning to identify IR primarily via family history, lipids and waist", "words": [{"boundingBox": [369, 1039, 434, 1038, 434, 1071, 369, 1071], "text": "They"}, {"boundingBox": [441, 1038, 485, 1038, 485, 1072, 441, 1071], "text": "are"}, {"boundingBox": [491, 1038, 600, 1038, 600, 1072, 491, 1072], "text": "learning"}, {"boundingBox": [606, 1038, 633, 1038, 633, 1072, 606, 1072], "text": "to"}, {"boundingBox": [640, 1038, 736, 1038, 736, 1073, 639, 1073], "text": "identify"}, {"boundingBox": [742, 1038, 774, 1038, 773, 1073, 742, 1073], "text": "IR"}, {"boundingBox": [782, 1038, 899, 1038, 899, 1074, 782, 1073], "text": "primarily"}, {"boundingBox": [906, 1038, 948, 1038, 947, 1074, 905, 1074], "text": "via"}, {"boundingBox": [954, 1037, 1034, 1037, 1033, 1074, 953, 1074], "text": "family"}, {"boundingBox": [1040, 1037, 1138, 1037, 1138, 1074, 1039, 1074], "text": "history,"}, {"boundingBox": [1145, 1037, 1218, 1037, 1217, 1074, 1144, 1074], "text": "lipids"}, {"boundingBox": [1224, 1037, 1275, 1037, 1274, 1074, 1223, 1074], "text": "and"}, {"boundingBox": [1281, 1037, 1356, 1037, 1355, 1074, 1280, 1074], "text": "waist"}]}, {"boundingBox": [369, 1075, 418, 1076, 418, 1100, 369, 1099], "text": "size", "words": [{"boundingBox": [368, 1074, 416, 1075, 416, 1099, 368, 1098], "text": "size"}]}, {"boundingBox": [338, 1123, 1315, 1128, 1314, 1160, 337, 1155], "text": "Few are using the NCEP ATPIII Guidelines as a strict model to identify", "words": [{"boundingBox": [366, 1124, 422, 1124, 423, 1156, 366, 1155], "text": "Few"}, {"boundingBox": [430, 1124, 474, 1125, 475, 1156, 431, 1156], "text": "are"}, {"boundingBox": [481, 1125, 554, 1126, 555, 1157, 481, 1156], "text": "using"}, {"boundingBox": [560, 1126, 606, 1126, 607, 1157, 561, 1157], "text": "the"}, {"boundingBox": [612, 1126, 696, 1127, 697, 1158, 613, 1157], "text": "NCEP"}, {"boundingBox": [704, 1127, 792, 1128, 793, 1158, 705, 1158], "text": "ATPIII", "confidence": "Low"}, {"boundingBox": [799, 1128, 943, 1128, 944, 1159, 800, 1158], "text": "Guidelines"}, {"boundingBox": [949, 1128, 985, 1129, 986, 1159, 951, 1159], "text": "as"}, {"boundingBox": [991, 1129, 1010, 1129, 1011, 1159, 993, 1159], "text": "a"}, {"boundingBox": [1016, 1129, 1079, 1129, 1081, 1159, 1018, 1159], "text": "strict"}, {"boundingBox": [1085, 1129, 1171, 1129, 1173, 1160, 1087, 1159], "text": "model"}, {"boundingBox": [1177, 1129, 1204, 1129, 1206, 1160, 1179, 1160], "text": "to"}, {"boundingBox": [1211, 1129, 1313, 1129, 1315, 1160, 1213, 1160], "text": "identify"}]}, {"boundingBox": [367, 1157, 1343, 1163, 1342, 1197, 366, 1192], "text": "the insulin resistant patient, and few use any office-based system beyond", "words": [{"boundingBox": [367, 1159, 408, 1159, 408, 1190, 367, 1190], "text": "the"}, {"boundingBox": [414, 1160, 503, 1161, 503, 1192, 414, 1191], "text": "insulin"}, {"boundingBox": [509, 1162, 626, 1163, 626, 1194, 509, 1192], "text": "resistant"}, {"boundingBox": [632, 1163, 732, 1165, 732, 1195, 632, 1194], "text": "patient,"}, {"boundingBox": [739, 1165, 790, 1165, 790, 1195, 739, 1195], "text": "and"}, {"boundingBox": [796, 1165, 843, 1165, 843, 1195, 796, 1195], "text": "few"}, {"boundingBox": [851, 1165, 905, 1166, 905, 1196, 851, 1195], "text": "use"}, {"boundingBox": [911, 1166, 960, 1166, 960, 1196, 911, 1196], "text": "any"}, {"boundingBox": [966, 1166, 1135, 1165, 1135, 1196, 966, 1196], "text": "office-based"}, {"boundingBox": [1141, 1165, 1231, 1164, 1231, 1196, 1141, 1196], "text": "system"}, {"boundingBox": [1243, 1164, 1342, 1163, 1342, 1195, 1244, 1196], "text": "beyond"}]}, {"boundingBox": [362, 1195, 1103, 1199, 1102, 1232, 361, 1228], "text": "simple random observation of the markers listed above.", "words": [{"boundingBox": [366, 1197, 453, 1197, 454, 1228, 367, 1227], "text": "simple"}, {"boundingBox": [459, 1197, 556, 1197, 557, 1229, 460, 1228], "text": "random"}, {"boundingBox": [572, 1197, 730, 1198, 731, 1231, 572, 1230], "text": "observation"}, {"boundingBox": [736, 1198, 762, 1198, 763, 1231, 737, 1231], "text": "of", "confidence": "Low"}, {"boundingBox": [768, 1198, 813, 1199, 814, 1231, 769, 1231], "text": "the"}, {"boundingBox": [819, 1199, 932, 1199, 933, 1231, 820, 1231], "text": "markers"}, {"boundingBox": [938, 1199, 1013, 1200, 1014, 1231, 939, 1231], "text": "listed"}, {"boundingBox": [1019, 1200, 1102, 1200, 1103, 1230, 1020, 1231], "text": "above.", "confidence": "Low"}]}, {"boundingBox": [362, 1243, 1360, 1248, 1359, 1282, 361, 1278], "text": "Beta cell preservation is a very important consideration in the treatment of", "words": [{"boundingBox": [366, 1244, 429, 1245, 429, 1278, 367, 1277], "text": "Beta"}, {"boundingBox": [435, 1245, 482, 1246, 483, 1278, 436, 1278], "text": "cell"}, {"boundingBox": [488, 1246, 655, 1248, 656, 1280, 489, 1278], "text": "preservation"}, {"boundingBox": [662, 1248, 687, 1248, 688, 1280, 663, 1280], "text": "is"}, {"boundingBox": [694, 1248, 711, 1248, 712, 1280, 695, 1280], "text": "a"}, {"boundingBox": [717, 1248, 775, 1249, 776, 1281, 718, 1280], "text": "very"}, {"boundingBox": [781, 1249, 912, 1249, 913, 1281, 783, 1281], "text": "important"}, {"boundingBox": [918, 1249, 1098, 1249, 1099, 1281, 920, 1281], "text": "consideration"}, {"boundingBox": [1105, 1249, 1132, 1249, 1134, 1281, 1106, 1281], "text": "in"}, {"boundingBox": [1139, 1249, 1182, 1249, 1183, 1281, 1140, 1281], "text": "the"}, {"boundingBox": [1188, 1249, 1318, 1248, 1320, 1281, 1189, 1281], "text": "treatment"}, {"boundingBox": [1325, 1248, 1359, 1248, 1361, 1280, 1326, 1281], "text": "of"}]}, {"boundingBox": [365, 1282, 618, 1281, 619, 1313, 366, 1315], "text": "patients with T2D.", "words": [{"boundingBox": [367, 1285, 473, 1283, 472, 1313, 366, 1314], "text": "patients"}, {"boundingBox": [479, 1283, 535, 1282, 534, 1313, 478, 1313], "text": "with"}, {"boundingBox": [545, 1282, 618, 1283, 617, 1315, 543, 1314], "text": "T2D.", "confidence": "Low"}]}, {"boundingBox": [361, 1332, 1334, 1335, 1333, 1369, 360, 1367], "text": "If convinced by clinical data that TZDs do, in fact, preserve beta cell", "words": [{"boundingBox": [365, 1334, 386, 1334, 386, 1366, 365, 1365], "text": "If"}, {"boundingBox": [393, 1334, 543, 1334, 542, 1367, 392, 1366], "text": "convinced"}, {"boundingBox": [549, 1334, 587, 1335, 586, 1367, 549, 1367], "text": "by"}, {"boundingBox": [593, 1335, 702, 1335, 701, 1368, 593, 1367], "text": "clinical"}, {"boundingBox": [708, 1335, 766, 1335, 766, 1368, 708, 1368], "text": "data"}, {"boundingBox": [773, 1335, 833, 1335, 833, 1369, 772, 1368], "text": "that"}, {"boundingBox": [840, 1335, 917, 1335, 917, 1369, 839, 1369], "text": "TZDs"}, {"boundingBox": [925, 1335, 967, 1335, 967, 1369, 925, 1369], "text": "do,"}, {"boundingBox": [973, 1335, 1002, 1335, 1002, 1369, 973, 1369], "text": "in"}, {"boundingBox": [1009, 1335, 1071, 1335, 1071, 1369, 1009, 1369], "text": "fact,"}, {"boundingBox": [1078, 1335, 1205, 1335, 1205, 1369, 1078, 1369], "text": "preserve"}, {"boundingBox": [1211, 1335, 1276, 1335, 1276, 1369, 1211, 1369], "text": "beta"}, {"boundingBox": [1282, 1335, 1332, 1335, 1333, 1369, 1282, 1369], "text": "cell"}]}, {"boundingBox": [366, 1367, 1335, 1370, 1334, 1406, 365, 1403], "text": "function, many (perhaps most) participants would feel compelled to", "words": [{"boundingBox": [367, 1370, 493, 1371, 492, 1402, 366, 1401], "text": "function,"}, {"boundingBox": [499, 1371, 581, 1372, 581, 1403, 498, 1402], "text": "many"}, {"boundingBox": [587, 1372, 713, 1373, 713, 1404, 587, 1403], "text": "(perhaps"}, {"boundingBox": [720, 1373, 804, 1373, 804, 1404, 719, 1404], "text": "most)"}, {"boundingBox": [810, 1373, 986, 1373, 985, 1405, 810, 1404], "text": "participants"}, {"boundingBox": [992, 1373, 1081, 1372, 1080, 1406, 992, 1405], "text": "would"}, {"boundingBox": [1087, 1372, 1143, 1372, 1142, 1406, 1087, 1406], "text": "feel"}, {"boundingBox": [1149, 1372, 1300, 1370, 1299, 1407, 1149, 1406], "text": "compelled", "confidence": "Low"}, {"boundingBox": [1306, 1370, 1335, 1370, 1334, 1407, 1306, 1407], "text": "to"}]}, {"boundingBox": [367, 1404, 797, 1409, 796, 1443, 366, 1437], "text": "use TZDs as first line therapy.", "words": [{"boundingBox": [367, 1405, 422, 1406, 421, 1437, 367, 1437], "text": "use"}, {"boundingBox": [428, 1406, 502, 1407, 501, 1437, 428, 1437], "text": "TZDs"}, {"boundingBox": [508, 1407, 544, 1407, 543, 1437, 507, 1437], "text": "as"}, {"boundingBox": [550, 1407, 609, 1408, 607, 1438, 549, 1437], "text": "first"}, {"boundingBox": [615, 1408, 670, 1409, 668, 1439, 614, 1438], "text": "line"}, {"boundingBox": [676, 1409, 798, 1410, 795, 1443, 674, 1439], "text": "therapy."}]}, {"boundingBox": [361, 1452, 1078, 1458, 1077, 1495, 360, 1489], "text": "Most believe intuitively that TZDs preserve beta cells.", "words": [{"boundingBox": [364, 1453, 431, 1454, 430, 1489, 363, 1487], "text": "Most"}, {"boundingBox": [437, 1454, 533, 1455, 532, 1491, 436, 1489], "text": "believe"}, {"boundingBox": [540, 1455, 667, 1457, 666, 1492, 539, 1491], "text": "intuitively"}, {"boundingBox": [673, 1457, 729, 1457, 728, 1493, 672, 1492], "text": "that"}, {"boundingBox": [735, 1458, 807, 1458, 806, 1493, 735, 1493], "text": "TZDs"}, {"boundingBox": [813, 1458, 933, 1460, 933, 1493, 813, 1493], "text": "preserve"}, {"boundingBox": [940, 1460, 1002, 1460, 1002, 1492, 940, 1492], "text": "beta"}, {"boundingBox": [1009, 1460, 1078, 1461, 1078, 1491, 1009, 1492], "text": "cells."}]}, {"boundingBox": [318, 1502, 352, 1504, 352, 1533, 318, 1531], "text": ".", "words": [{"boundingBox": [323, 1502, 343, 1503, 341, 1532, 322, 1531], "text": "."}]}, {"boundingBox": [361, 1504, 1311, 1510, 1310, 1545, 360, 1540], "text": "Across all groups, the most commonly mentioned reasons NOT to", "words": [{"boundingBox": [365, 1505, 468, 1506, 469, 1539, 366, 1538], "text": "Across"}, {"boundingBox": [474, 1506, 509, 1507, 509, 1540, 475, 1539], "text": "all"}, {"boundingBox": [515, 1507, 629, 1508, 629, 1542, 516, 1540], "text": "groups,"}, {"boundingBox": [635, 1508, 680, 1509, 680, 1542, 635, 1542], "text": "the"}, {"boundingBox": [686, 1509, 763, 1509, 763, 1543, 686, 1542], "text": "most"}, {"boundingBox": [770, 1509, 922, 1510, 922, 1544, 770, 1543], "text": "commonly"}, {"boundingBox": [928, 1510, 1082, 1510, 1082, 1544, 928, 1544], "text": "mentioned"}, {"boundingBox": [1089, 1510, 1204, 1510, 1204, 1544, 1088, 1544], "text": "reasons"}, {"boundingBox": [1211, 1510, 1277, 1510, 1276, 1544, 1210, 1544], "text": "NOT"}, {"boundingBox": [1284, 1510, 1311, 1510, 1311, 1544, 1283, 1544], "text": "to"}]}, {"boundingBox": [367, 1540, 1174, 1546, 1173, 1582, 366, 1575], "text": "prescribe TZDs are 1) Cost, 2) Edema/weight gain, and 3)", "words": [{"boundingBox": [367, 1544, 502, 1544, 502, 1575, 368, 1572], "text": "prescribe"}, {"boundingBox": [511, 1544, 585, 1544, 585, 1576, 511, 1575], "text": "TZDs"}, {"boundingBox": [592, 1543, 638, 1544, 638, 1577, 592, 1576], "text": "are"}, {"boundingBox": [648, 1544, 675, 1544, 675, 1577, 648, 1577], "text": "1)"}, {"boundingBox": [681, 1544, 758, 1544, 758, 1579, 681, 1578], "text": "Cost,"}, {"boundingBox": [764, 1544, 793, 1544, 793, 1579, 764, 1579], "text": "2)"}, {"boundingBox": [799, 1544, 1007, 1545, 1007, 1581, 799, 1579], "text": "Edema/weight"}, {"boundingBox": [1012, 1545, 1084, 1546, 1084, 1582, 1012, 1581], "text": "gain,"}, {"boundingBox": [1090, 1546, 1147, 1547, 1147, 1582, 1090, 1582], "text": "and"}, {"boundingBox": [1153, 1547, 1173, 1547, 1172, 1583, 1152, 1582], "text": "3)"}]}, {"boundingBox": [366, 1575, 608, 1579, 607, 1610, 365, 1605], "text": "Reimbursement.", "words": [{"boundingBox": [366, 1575, 607, 1581, 606, 1610, 366, 1605], "text": "Reimbursement."}]}, {"boundingBox": [338, 1627, 1299, 1633, 1298, 1671, 337, 1665], "text": "In Dallas and Miami, Steve Crow asked his High Potential groups \"If a", "words": [{"boundingBox": [363, 1632, 392, 1632, 392, 1662, 363, 1662], "text": "In"}, {"boundingBox": [398, 1633, 484, 1633, 484, 1663, 398, 1662], "text": "Dallas"}, {"boundingBox": [490, 1633, 542, 1634, 542, 1663, 490, 1663], "text": "and"}, {"boundingBox": [548, 1634, 642, 1634, 641, 1664, 547, 1663], "text": "Miami,"}, {"boundingBox": [648, 1634, 724, 1635, 724, 1665, 647, 1664], "text": "Steve"}, {"boundingBox": [732, 1635, 797, 1635, 797, 1666, 731, 1665], "text": "Crow"}, {"boundingBox": [809, 1635, 892, 1635, 891, 1667, 808, 1666], "text": "asked"}, {"boundingBox": [897, 1635, 940, 1635, 939, 1667, 896, 1667], "text": "his"}, {"boundingBox": [945, 1635, 1009, 1635, 1008, 1668, 944, 1667], "text": "High"}, {"boundingBox": [1016, 1635, 1137, 1634, 1136, 1669, 1015, 1668], "text": "Potential"}, {"boundingBox": [1143, 1634, 1235, 1633, 1234, 1671, 1142, 1670], "text": "groups"}, {"boundingBox": [1241, 1633, 1272, 1633, 1271, 1671, 1240, 1671], "text": "\"If", "confidence": "Low"}, {"boundingBox": [1278, 1633, 1297, 1633, 1295, 1672, 1276, 1671], "text": "a"}]}, {"boundingBox": [364, 1665, 1262, 1670, 1261, 1705, 363, 1700], "text": "doctor accepts IR as the core defect, and agrees that TZDs directly", "words": [{"boundingBox": [366, 1668, 449, 1668, 449, 1699, 366, 1699], "text": "doctor"}, {"boundingBox": [455, 1669, 561, 1669, 560, 1699, 455, 1699], "text": "accepts"}, {"boundingBox": [567, 1669, 599, 1669, 598, 1699, 566, 1699], "text": "IR"}, {"boundingBox": [607, 1669, 642, 1669, 641, 1700, 607, 1699], "text": "as"}, {"boundingBox": [648, 1669, 692, 1670, 691, 1700, 647, 1700], "text": "the"}, {"boundingBox": [698, 1670, 761, 1670, 760, 1700, 698, 1700], "text": "core"}, {"boundingBox": [769, 1670, 858, 1670, 857, 1701, 768, 1700], "text": "defect,"}, {"boundingBox": [864, 1670, 917, 1670, 916, 1702, 863, 1701], "text": "and"}, {"boundingBox": [923, 1670, 1018, 1670, 1017, 1703, 922, 1702], "text": "agrees"}, {"boundingBox": [1024, 1670, 1079, 1670, 1077, 1703, 1023, 1703], "text": "that"}, {"boundingBox": [1085, 1670, 1162, 1670, 1160, 1704, 1083, 1703], "text": "TZDs"}, {"boundingBox": [1168, 1670, 1261, 1670, 1259, 1706, 1166, 1704], "text": "directly"}]}, {"boundingBox": [362, 1700, 1180, 1706, 1179, 1739, 361, 1733], "text": "address IR, what would preclude the use of TZDs as primary", "words": [{"boundingBox": [364, 1700, 470, 1701, 470, 1734, 365, 1733], "text": "address"}, {"boundingBox": [477, 1702, 518, 1702, 518, 1735, 477, 1734], "text": "IR,"}, {"boundingBox": [524, 1702, 591, 1703, 591, 1735, 524, 1735], "text": "what"}, {"boundingBox": [598, 1703, 676, 1704, 675, 1736, 598, 1735], "text": "would"}, {"boundingBox": [682, 1704, 801, 1705, 800, 1737, 682, 1736], "text": "preclude"}, {"boundingBox": [807, 1705, 851, 1705, 850, 1737, 807, 1737], "text": "the"}, {"boundingBox": [857, 1705, 909, 1705, 908, 1738, 857, 1737], "text": "use"}, {"boundingBox": [916, 1705, 946, 1706, 945, 1738, 915, 1738], "text": "of"}, {"boundingBox": [952, 1706, 1026, 1706, 1025, 1738, 952, 1738], "text": "TZDs"}, {"boundingBox": [1032, 1706, 1065, 1706, 1064, 1739, 1031, 1739], "text": "as"}, {"boundingBox": [1071, 1706, 1179, 1707, 1178, 1739, 1070, 1739], "text": "primary"}]}, {"boundingBox": [363, 1735, 1265, 1740, 1264, 1776, 362, 1771], "text": "mono/combo therapy?\" Responses included, in no particular order:", "words": [{"boundingBox": [363, 1735, 539, 1737, 539, 1773, 363, 1771], "text": "mono/combo"}, {"boundingBox": [547, 1737, 683, 1738, 682, 1773, 546, 1773], "text": "therapy?\""}, {"boundingBox": [690, 1738, 840, 1739, 839, 1774, 689, 1773], "text": "Responses"}, {"boundingBox": [847, 1739, 971, 1740, 970, 1775, 846, 1774], "text": "included,"}, {"boundingBox": [978, 1740, 1002, 1740, 1001, 1775, 977, 1775], "text": "in"}, {"boundingBox": [1009, 1740, 1045, 1740, 1044, 1775, 1008, 1775], "text": "no"}, {"boundingBox": [1052, 1741, 1176, 1741, 1175, 1775, 1051, 1775], "text": "particular"}, {"boundingBox": [1183, 1741, 1264, 1742, 1263, 1775, 1182, 1775], "text": "order:"}]}, {"boundingBox": [752, 1848, 771, 1842, 775, 1870, 757, 1876], "text": "8", "words": [{"boundingBox": [753, 1846, 769, 1841, 778, 1868, 762, 1874], "text": "8"}]}, {"boundingBox": [58, 2068, 492, 2069, 492, 2099, 57, 2098], "text": "Confidential - Subject to Protective Order", "words": [{"boundingBox": [58, 2069, 181, 2069, 181, 2098, 59, 2099], "text": "Confidential"}, {"boundingBox": [187, 2069, 202, 2069, 202, 2098, 187, 2098], "text": "-"}, {"boundingBox": [208, 2069, 285, 2069, 285, 2098, 208, 2098], "text": "Subject"}, {"boundingBox": [291, 2069, 312, 2069, 312, 2098, 290, 2098], "text": "to"}, {"boundingBox": [318, 2069, 425, 2069, 424, 2099, 317, 2098], "text": "Protective"}, {"boundingBox": [431, 2069, 493, 2069, 491, 2100, 430, 2099], "text": "Order"}]}, {"boundingBox": [1216, 2067, 1474, 2067, 1473, 2095, 1215, 2094], "text": "TAK-DALYRI-00058804", "words": [{"boundingBox": [1220, 2067, 1474, 2068, 1474, 2094, 1220, 2094], "text": "TAK-DALYRI-00058804"}]}, {"boundingBox": [1191, 2101, 1544, 2101, 1544, 2130, 1192, 2130], "text": "Produced in MDL on 09/17/12", "words": [{"boundingBox": [1192, 2102, 1304, 2103, 1305, 2129, 1192, 2129], "text": "Produced"}, {"boundingBox": [1310, 2103, 1335, 2103, 1335, 2129, 1310, 2129], "text": "in"}, {"boundingBox": [1340, 2103, 1395, 2103, 1396, 2129, 1340, 2129], "text": "MDL"}, {"boundingBox": [1401, 2103, 1433, 2102, 1433, 2130, 1401, 2129], "text": "on"}, {"boundingBox": [1438, 2102, 1543, 2101, 1544, 2131, 1438, 2130], "text": "09/17/12"}]}, {"boundingBox": [384, 2195, 1318, 2192, 1319, 2230, 385, 2232], "text": "Source: https://www.induptrygacoooogts.ucsf.edu/docs/rnjf0226", "words": [{"boundingBox": [387, 2196, 502, 2196, 502, 2231, 387, 2231], "text": "Source:"}, {"boundingBox": [508, 2196, 1317, 2193, 1318, 2230, 509, 2231], "text": "https://www.induptrygacoooogts.ucsf.edu/docs/rnjf0226", "confidence": "Low"}]}]}]}